Where Ionis Pharmaceuticals Stands With Analysts
Where Ionis Pharmaceuticals Stands With Analysts
ionis pharmaceuticals目前與分析師的立場
A clear picture...Ionis Pharmaceuticals (NASDAQ:IONS) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Ionis Pharmaceuticals（納斯達克：IONS）在上個季度接受了4位分析師的分析，從看好到謹慎看淡，觀點各異。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high estimate of $70.00, and a low estimate of $55.00. Consistency is reflected as the current average remains at the same level as the previous average price target.
分析師評估的12個月價格目標揭示了更多見解，其中包括平均目標爲$62.5，最高估價爲$70.00，最低估價爲$55.00。當前平均值與先前的平均價格目標保持一致。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A clear picture...
通過對...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間